Company Profile
Toranomon Impact Capital LLC is an impact-oriented venture capital firm based in Tokyo, Japan. The firm was established through a collaboration between Monex Ventures Inc. and Capital Medica Ventures Co., Ltd. Its primary objective is to manage the Tokyo Wellness Impact Investment Limited Partnership, also known as the Tokyo Wellness Impact Fund (TWIF). The firm is dedicated to fostering social impact alongside financial returns by investing in startups focused on solving challenges within the wellness domain.
The firm was officially established on October 11, 2022, with the Tokyo Wellness Impact Fund being formed on March 31, 2023. Toranomon Impact Capital aims to address domestic issues across four key wellness areas: Social/Economic, Healthcare, Care, and Medical. They employ an Impact Measurement and Management (IMM) framework to provide hands-on support to entrepreneurs, guiding them through a process of goal setting, gap analysis, and strategic implementation to enhance corporate value. The ultimate goal is to facilitate responsible exits, such as Impact IPOs or Exit to Community scenarios.
The Tokyo Wellness Impact Fund is targeting a total investment amount of 10 billion yen. Notable investments by the fund include 株式会社CaTe, a company developing applications for cardiac rehabilitation treatment. Other portfolio companies mentioned include Heal-III, operating in the entertainment software industry, and Melon, which provides B2C non-financial services.
The leadership team includes Hiroshi Aikawa, a representative from Monex Ventures Inc., and Takeshi Aoki, the representative director of Capital Medica Ventures Co., Ltd. Seiichiro Wada, President of Monex Ventures Inc., is also listed as a Representative Partner for Toranomon Impact Capital LLC. The firm actively seeks impact capitalists and communicators to support its mission of accompanying and nurturing entrepreneurs.
News & Signals (0)
No linked news activity found for this company.